9th Annual Biomarkers Congress

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2010 Serum chitotriosidase activity and Wegener's granulomatosis. Clin Biochem. 2010; 43: 512-514
2. 2009 Surgical interventions and localized therapy for Wegener’s granulomatosis. Curr Opin Rheum. 2009; 22:29-36.
3. 2009 Limited utility of rapamycin in severe, refractory Wegener’s granulomatosis J Rheumatol. 2009; 36:116-9
4. 2009 Vasculitis Peripheral Arterial Disease: Disorders of the Arterial Circulation. Edited by Dieter RS; McGraw-Hill. Chapter 14. 198-231. 2009
5. 2009 Sinonasal Wegener granulomatosis: a single institution experience with 120 cases Laryngoscope. 2009; 119: 757-61
6. 2009 Gynecologic vasculitis. An Analysis of 163 Patients Medicine 2009; 88: 169-181
7. 2009 Vasculitis: another perspective on when and how it begins The Rheumatologist. 2009; 3: 1, 16-19
8. 2009 Glycosylation of proteinase 3 is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener’s granulomatosis Clin Exp Rheumatol. 2009; 27: 46 - 52
9. 2009 Takayasu arteritis and giant cell arteritis. A spectrum within the same disease? Medicine. 2009; 88: 221-6
10. 2009 Therapeutic dilemma: persistent hematuria after induction of remission in Wegener’s granulomatosis Medicine. 2009; 88: 315-21
11. 2009 Takayasu’s Arteritis Cleveland Clinic’s Current Clinical Medicine.
12. 2009 Comparison of disease activity measures for ANCA-associated vasculitis. Ann Rheum Dis. 2009; 68:103-6
13. 2008 Single organ vasculitis Curr Opin Rheumatol. 2008; 20: 40-46
14. 2008 Large and medium vessel vasculitis – clinical features and treatment Kidney in Systemic Autoimmune Disease. Chapter 10.Editors. C. Pusey and J. Mason. Publisher. Elsevier Saunders. 2008; 7:175-93
15. 2008 Vasculitis involving the breast A clinical and histological analysis of 34 patients. Medicine. 2008; 87: 61-9
16. 2008 Discussion of the 2007 British Society of Rheumatology guidelines for management of ANCA-associated vasculiti Nature Clin Pract Rheum. 2008; 4: 284-5
17. 2008 Wegener's Granulomatosis Etanercept Trial Research Group. Effects of glucocorticoids on weight change during the treatment Wegener's granulomatosis. Arthritis & Rheum. 2008; 59:746-53
18. 2008 Discussion of the 2007 British Society for Rheumatology guidelines for management of ANCA-associated vasculitis Nature Clinical Practice Rheumatology. 4:284-5, 2008
19. 2008 Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up Ann Rheum Dis 2008; 67; 1567-1569.
20. 2008 Disease patterns in vasculitis – still a mystery Bull NYU Hosp Joint Dis. 2008; 66: 224-7
21. 2007 ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis Am J Med. 2007; 120:643.e9-14
22. 2007 Substitution of methotrexate for cyclophosphamide in Wegener’s granulomatosis. A 12-year single-practice experience Medicine. 2007; 86: 86(5):269-77
23. 2007 For the WGET Research Group. Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis Ann Intern Med. 2007; 147: 611-19.
24. 2007 Takayasu arteritis: what is the long-term prognosis? Rheum Dis Clin NA. 2007; 33: 777-86
25. 2007 Vasculitis Chapter 37. 449-66. In 2nd Edition. Contemporary Targeted Therapies in Rheumatology. Edited by JS Smolen and PE Lipsky. Martin Dunitz. London and NY
26. 2007 Limitations of therapy and guarded prognosis in an American cohort of Takayasu's arteritis patients Arthritis Rheum. 2007; 56: 1000-1009
27. 2007 Anti-endothelial cell antibodies in patients with Wegener's granulomatosis: prevalence and correlation with disease activity and manifestations J Rheumatol. 2007.
28. 2007 Should Induction Therapy With High-Dose Glucocorticoids Be Used In The Standard Treatment Of All Patients With Giant Cell Arteritis? Nature Med Clin Pract. 2007; 3: 132-133
29. 2007 Rheumatic Diseases of the Cardiovascular System BRAUNWALD’s HEART DISEASE, 8TH Edition. Editors: E Braunwald, D. Zipes, P. Libby. Chapter 84. pp 2101- 2116.
30. 2007 Controversies in small vessel vasculitis - comparing rheumatology and nephrology views. Curr Opin Rheumatol. 2007; 19: 1-9.
31. 2007 Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: A placebo-controlled randomized trial Ann Intern Med. 2007; 146: 621-30
32. 2007 Vasculitis and Otolaryngology Head and Neck manifestations of Systemic Diseases. Editors: J Harris and M Weisman.
33. 2006 Antiplatelet and anticoagulant therapy in patients with giant cell arteritis Arthritis Rheum. 2006; 54: 3306 - 3309
34. 2006 Standardized ANCA testing in an inception cohort of Wegener’s granulomatosis patients with active disease Arthritis Rheum. 2006.
35. 2006 Solid malignancies among patients in the Wegener's granulomatosis etanercept trial Arthritis Rheum. 2006; 54: 1608 - 1618
36. 2006 Can methotrexate replace cyclophosphamide in the treatment of a subset of Wegener's granulomatosis and microscopic polyangiitis? Nature Clin Pract Rheum 2006; 2: 70 - 71
37. 2006 Solid malignancies among patients in the Wegener's granulomatosis etanercept trial Arthritis Rheum. 2006; 54: 1608 - 1618.
38. 2005 Incidence of venous thrombotic events among patients with Wegener's granulomatosis Ann Intern Med 2005; 142: 620-6
39. 2005 Etanercept plus standard therapy in patients Wegener’s granulomatosis. N Engl J Med. 352:351-61.2005.
40. 2005 A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis Arthritis Rheum. 2005; 52:902-10
41. 2005 Implications of ANCA status when switching to maintenance therapy. Arthritis Rheum (Arthritis Care & Res). 53:1-2. 2005.
42. 2005 Wegener’s granulomatosis Electronic Publication
43. 2005 Giant cell arteritis and polymyalgia rheumatica Electronic Publication
44. 2005 Takayasu’s arteritis VASCULAR MEDICINE, A companion to Braunwald’s Heart Disease. 2nd Edition
45. 2005 Takayasu’s arteritis Electronic Publication
46. 2005 Systemic vasculitis Chapter 32. In The Cleveland ClinicIntensive Review of Internal Medicine. 4th Edition. Editors: JK Stoller, FA Michota, BF Mandell. Lippincott Williams and Wilkins. Philadelphia. 2005. pp.394-406
47. 2005 Wegener's granulomatosis RHEUMATOLOGY. 4TH EDITION.
48. 2005 Damage caused by Wegener's granulomatosis and its treatment: Prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET). Arthritis Rheum. 2005; 28; 52:2168-2178
49. 2005 Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis J Rheumatol. 2005; 32: 2488-95
50. 2005 Are there different forms of life in the antineutrophil cytoplasmic antibody universe? Ann Intern Med. 2005; 143: 683-685
51. 2005 Herpes Zoster in immunocompromised patients. Incidence, timing and risk factors Am J Med. 2005; 118: e1409-1416.
52. 2005 new era in the treatment of systemic vasculitis Nature. Clinical Practice. 2005
53. 2005 Rheumatic Diseases of the Cardiovascular System BRAUNWALD’s HEART DISEASE, 7TH Edition. Editors: E Braunwald, D. Zipes, P. Libby. Chapter 82. pp 2101- 2116. 2005
54. 2005 Vasculitis Chapter 111. In Hospital Medicine,2nd Edition. Editors: RM Wachter, L Goldman, H Hollander. Lippincott Williams and Wilkins. Philadelphia. 2005. pp.1121-33
55. 2004 Determinants of vessel targeting in vasculitis Clin Devel Immunology. 2004;11:275-9.
56. 2004 An analysis of CTLA-4 and proinflammatory cytokine genes in Wegener’s granulomatosis Arthritis Rheum. 2004;50:2645-2650.
57. 2004 Advances in medical and surgical treatment of Takayasu's arteritis Curr Opin Rheumatol. 17:16-24.2004
58. 2004 Large Vessel Vasculitis - Takayasu’s arteritis Chapter 10. In Handbook of Systemic Autoimmune Diseases. Neurologic Involvement In Systemic Autoimmune Diseases. Edit. D. Erkan and SR Levine. pp. 181-191
59. 2004 Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum. 2004; 50:2296-2304
60. 2004 Methotrexate in managing systemic vasculitis The Journal of Musculoskeletal Medicine 21:127-128
61. 2004 Takayasu’s arteritis: vascular interventions and outcomes. J Rheumatol. 31: 102-6.2004
62. 2003 Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener’s granulomatosis J Rheumatol. 2003;30:1541-7.
63. 2003 Treatment of subglottic stenosis, due to Wegener’s granulomatosis, with intralesional corticosteroids and dilation . J Rheumatol. 2003; 30:1017-21
64. 2003 Prevalence of antineutrophil cytoplasmic antibobies in patients with various pulmonary diseases or multiorgan dysfunction Arthritis Rheum (Arthritis Care Res). 2003;49:151-5.
65. 2003 “Four Diagnostic Exercises”. Clin Exp Rheumatol. 21:135-137,
66. 2003 Domains of health-related quality of life important to patients with giant cell arteritis. Arthritis Rheum. Arthritis Care Res. 49:819-25
67. 2003 Crohn’s disease plus Takayasu’s arteritis: more than coincidence? Ann Med Interne. 2003;154:75-76
68. 2003 Large vessel vasculitis. Unresolved issues Arthritis Rheum.48
69. 2003 Open label trial of tamoxifen in scleroderma Clin Exp Rheumatol. 21:99-102
70. 2003 Systemic necrotizing vasculitis Fitzpatrick’s Dermatology in General Medicine. Editors: IM Freedberg, AZ Eisen, K Wollf el al. 6th Edit. McGraw Hill. 2003. Chapter 174. 1718-27
71. 2003 Limited versus severe Wegener’s granulomatosis Baseline data on patients in the Wegener’s granulomatosis etanercept trial. Arthritis Rheum. 2003; 48:2299-2309
72. 2003 Wegener's Granulomatosis and Lymphomatoid Granulomatosis RHEUMATOLOGY. 3rd Edition. Chapter 148.1635-48
73. 2002 Clinical spectrum of antineutrophil cytoplasmic antibodies Electronic Publication
74. 2002 Pharmacology and side effects of cyclosporin and tacrolimus Electronic Publication
75. 2002 Alternative agents in the treatment of Wegener’s granulomatosis and microscopic polyangiitis Electronic Publication
76. 2002 Treatment of Wegener's granulomatosis and microscopic polyangiitis Electronic Publication
77. 2002 Treatment of Wegener's granulomatosis Electronic Publication
78. 2002 Clinical manifestations of Wegener's granulomatosis Electronic Publication
79. 2002 Systemic vasculitis Intensive Review of Internal Medicine. Lippincott Williams and Wilkins. Pp 404-16.
80. 2002 Treatment of giant cell arteritis: where we have been and why we must move on Proceedings of the 10th International Vasculitis and ANCA Workshop. Cleveland Clinic Journal of Medicine. 69(S):117-120
81. 2002 Wegener'sgranulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s J Rheumatol. 2002; 29:309-16
82. 2002 Vasculitis TARGETED THERAPY in RHEUMATOLOGY. Chapter 35.583-601
83. 2002 SLE and the cardiovascular system: vasculitis Systemic Lupus Erythematosus, 4th Edition. Ed: RG Lahita, Chapter 33.
84. 2002 Takayasu’s arteritis: utility of magnetic resonance imaging in diagnosis and treatment Arthritis Rheum. 46:1634-42.
85. 2002 Design of the Wegener’s granulomatosis etanercept trial (WGET) Controlled Clin Trials. 23:450-68
86. 2002 Sarcoidosis and vasculitis Inflammatory Diseases of Blood Vessels. Marcel Dekker,Inc. Editors: Hoffman GS, Weyand C
87. 2002 Wegener’s granulomatosis. Clinical features. Inflammatory Diseases of Blood Vessels. Marcel Dekker,Inc. Editors: Hoffman GS, Weyand C
88. 2002 Patients' perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships; a comparison with Wegener's granulomatosis Arthritis Rheum/Arthritis Care Res. 2002;47:196-201
89. 2002 Mechanism of action and general toxicity of alkylating agents Cleveland Clinic – Disease Management Textbook
90. 2002 General principles of the use of cyclophosphamide in rheumatic and renal diseases. Electronic Publication
91. 2002 Overview of the major antirheumatic drugs Electronic Publication
92. 2002 ANCA (antineutrophil cytoplasmic antibodies): pathogenesis Electronic Publication
93. 2001 Etanercept combined with conventional treatment in Wegener’s granulomatosis Arthritis Rheum. 44:1149-54
94. 2001 Methotrexate as an alternative to classical immuno-suppressive therapies. Disease Modifying Therapy in Vasculitis. Ed: Kallenberg CGM and Cohen Tervaert JW. Birkhauser
95. 2001 Vasculitis: A collection of pearls and myths Rheum Dis Clin. 27: 677-728.
96. 2001 A disease-specific activity index for Wegener’s Granulomatosis: Modification of the Birmingham Vasculitis Activity Score. Arthritis Rheum. 44:912-920
97. 2001 A 29 year old female with flank pain, hypertension and gross hematuria Internal Medicine Pearls II. Edit: Heffner JE and Sahn SA. 2001. pp175-178
98. 2001 Rheumatic diseases and the cardiovascular system Chapter 67. pp. 2199-2210. In: Heart Disease: A Textbook of Cardiovascular Medicine. 6th Edition. Edit: Braunwald E, Zipes DP, Libby P. WB Saunders Co
99. 2001 Methotrexate as an alternative to classical immunosuppressive therapies. Vasculitis. Edit: Kallenberg C
100. 2001 Nasal cavity squamous cell carcinoma in Wegener’s granulomatosis Arch Otolaryngol Head Neck Surg. 127:709-13
101. 2001 Pathogenesis: Immunogenetic factors Alarcon G, Hoffman GS. Clinical Rheumatology. Systemic Vasculitis. 15:239-58
102. 2001 The Vasculitides: Wegener granulomatosis and Churg Strauss vasculitis Primer on the Rheumatic Diseases
103. 2001 ACP-ASIM's PIER Project; Module: Vasculitis Extensive writings RheumatologyWeb.com 1999- 2003
104. 2000 Wegener’s granulomatosis: Pitfalls in the management of pulmonary disease. J Rheumatol 27:2511-2
105. 2000 Hepatitis A infection mimicking adult onset Still’s disease J Rheumatol 27:1792-5.
106. 2000 Vasculitis Pp. 931-42. In Hospital Medicine. Edit: Wachter RM, Goldman L, Hollander H. Lippincott, Williams and Wilkins, Phila. 1st Edition
107. 2000 Vasculitis - Its many forms Pp 1404-18. In Kelly’s Textbook of Internal Medicine, 4th Edition. Edit: Humes HD, et al. Lippincott, Williams and Wilkins
108. 2000 Takayasu's disease: Non-specific aortoarteritis Chapter 21, pp. 364-73. In: Vascular Surgery. Ed: Rutherford, W.B. Saunders Co. Phila
109. 2000 Temporal concurrence of vasculitis and cancer: a report of 12 cases Arthritis Care Res. 13:417-23
110. 2000 Vasculitis at the millennium Curr Opin Rheumatol 12:1-2
111. 2000 Large vessel vasculitis Clin Exp Immunol 120 (suppl 1):30-31
112. 2000 Collaborative studies in Europe and the USA: where to go? Clin Exp Immunol 120 (suppl 1):17
113. 2000 Environmental factors in systemic vasculitis Clin Exp Immunol 120 (suppl 1):10-11
114. 2000 Sarcoidosis and systemic vasculitis Sem Arthritis Rheum 30:33-46
115. 2000 Study of 52 patients with idio-pathic aortitis from a cohort of 1,204 surgical cases Arthritis Rheum 43:901-907
116. 2000 Longterm outcome of Wegener’s granulomatosis in patients with renal disease requiring dialysis J Rheumatol 27:1237-40.
117. 1999 Vasculitis syndromes Curr Opin Rheumatol 11:1-2
118. 1999 Wegener’s granulomatosis presenting as a renal mass J Rheumatol 26:457-8
119. 1999 Multicentric reticulohistiocytosis: a mimic of gout and rheumatoid arthritis. Cleve Clin J Med 66:166-170
120. 1999 Aneurysms and hypermobility Cleve Clin J Med 66:426-33
121. 1999 Necrotizing systemic arteritis Textbook of Dermatology in General Medicine. Eds: Fitzpatrick, et al, McGraw Hill, 1999. Chapter 175. 2034-2044
122. 1999 Clinical utility of antineutrophil cytoplasmic antibody (ANCA) testing Clin Diag Lab Immunol 6:645-51
123. 1999 Wegener’s granulomatosis Thorax: Rare Diseases Series. 54:629-37
124. 1999 Systemic necrotizing arteritis. Current Practice of Medicine , Rapid Science Publishers 2:175-185
125. 1999 Estradiol enhances endothelial cell interactions with extracellular matrix proteins via an increase in integrin expression and function Angiogenesis. 3:271-80.
126. 1998 Wegener’s granulomatosis: role of environmental exposures Clin Exp Rheumatol 16:669-74
127. 1998 Wegener’s granulomatosis Sem Resp Crit Care Med 19:13-25
128. 1998 Vasculitis Curr Opin Rheumatol 10:1-2
129. 1998 Classification of the systemic vasculitides: antineutrophil cytoplasmic antibodies, consensus and controversy Clin Exp Rheumatol 16:111-115
130. 1998 Systemic vasculitis. In: Textbook of Clinical Rheumatology Hwee-Siew Howe and Pao Hsii Feng, National Arthritis Foundation, Singapore.1998. Pp.152-166
131. 1998 SLE and the cardiovascular system: vasculitis. Systemic Lupus Erythematosus, 3rd Edition. Ed: RG Lahita, Chapter 33.707-717
132. 1998 Wegener’s granulomatosis Chapter 22. In: Rheumatology, 2nd Edition. Eds: JH Klippel and P. Dieppe, Mosby, London. Pp.22.1-10
133. 1998 Antineutrophil cytoplasmic antibodies Arthritis Rheum 41:1521- 37
134. 1998 Antineutrophil cytoplasmic antibodies Bull Rheum Dis.
135. 1998 Wegener’s granulomatosis: Patient-reported effects of disease on health, function and income Arthritis Rheum 41: 2257-62
136. 1998 The differential diagnosis of polyarthritis Chapter 29. In: Cleveland Clinic Intensive Review of Internal Medicine. Eds. Stoller JK, Longworth DL, Williams and Wilkins, Baltimore. pp. 289-302
137. 1998 Vasculitis: Textbook of Rheumatology Update Series (monograph). WB Saunders, 28:1-18
138. 1998 Wegener’s granulomatosis: controversies and current concepts Comprehensive Therapy. 24:421-440
139. 1998 The clinical application of “edema-weighted” magnetic resonance imaging in Takayasu’s arteritis Internat J Cardiol 66 (S):151-159
140. 1998 Surrogate markers of disease activity in patients with Takayasu’s arteritis Internat J Cardiol 66 (S1):191-194
141. 1998 Pulmonary vasculitis Clin Chest Med 19:759-776
142. 1997 The perils of not treating hyperuricemia CCJM 64:215
143. 1997 Wegener’s granulomatosis: Mediastinal mass and hilar adenopathy. Arthritis Rheum. 1997; 40:1992-7
144. 1997 Methotrexate use in systemic vasculitis Rheum Dis Clin NA 23:841-853
145. 1997 Analysis of FcgR II gene polymorphisms in Wegener’s granulomatosis Exp Clin Immunogenet 14:183-95
146. 1997 Treatment of Wegener’s granulomatosis: time to change the standard of care? Arthritis Rheum 40:2099-2104
147. 1997 Arthritis due to deposition of calcium crystals Harrison’s Principles of Internal Medicine, 14th Edition. Eds: JD Wilson et al., McGraw Hill
148. 1997 Vasculitis: treatment Primer on the Rheumatic Diseases, 11th Edition. Ed: JH Klippel, Arthritis Foundation, 1997, pg 300-304
149. 1997 Systemic vasculitis Peripheral Vascular Diseases. Edit: Young JR, Olin JW, Bartholomew JR. Mosby Year Book, St. Louis,
150. 1997 Vasculitis syndromes Curr Op Rheumatol 9:1-2
151. 1996 Immunosuppressive therapy is always required for the treatment of limited Wegener’s granulomatosis. Pro. Controversies in vasculitis Sarcoidosis, Vasculitis and Diffuse Lung Disease, 13:249-52
152. 1996 The use of intravenous immunoglobulin in rheumatic diseases. CCJM, 63:340-343
153. 1996 Rheumatoid arthritis Current Therapy in Allergy, Immunology and Rheumatology. Ed: LM Lichtenstein and AS Fauci. Mosby, 5th Edition, 186-93
154. 1996 ANCAs: Are they important? J Nephrol 9:1-3
155. 1996 The use of intravenous immunoglobulin in rheumatic diseases CCJM, 63:340-343
156. 1996 The epidemiology of Wegener’s granulomatosis Arthritis Rheum 39:87-92
157. 1996 Takayasu's arteritis: lessons from the American National Institutes of Health experience Internat J Cardiol 54(S):83-86
158. 1996 Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener's granulomatosis Ann Intern Med 124:477-84
159. 1996 Clinical features and management of subglottic stenosis in patients with Wegener’s granulomatosis Arthritis Rheum 39:1754-60
160. 1995 Lack of sensitivity of indium-111 mixed leukocyte scans for active disease in Takayasu’s arteritis J Rheumatol 22:478-81
161. 1995 Wegener’s granulomatosis Rheum Dis Clinics NA 21:949-86
162. 1995 Takayasu's disease Vascular Surgery. Ed: Rutherford, W.B. Saunders Co. Phila.
163. 1995 Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis Am J Respir Crit Care Med 151:795-9
164. 1995 Granulomatous hepatitis Principles and Practice of Infectious Diseases, 4th Edition, pp. 1159-64. Eds: G. Mandel, G.E. Bennett, R. Dolin. J. Wiley and Sons, Inc.
165. 1995 Immunomodulating pharmaceuticals Chapter 129, pp. 1980-92. In: Clinical Immunology. Editor: R. Rich
166. 1995 Glucocorticoids Clinical Immunology. Editor: R. Rich,
167. 1995 Advances in Wegener’s granulomatosis Hospital Practice 10:33-40
168. 1995 Classics in Medicine: Wegener’s granulomatosis: The path traveled since 1931 Medicine 73(6):325-9
169. 1995 Immunosuppression: new perspectives in the treatment of the systemic vasculitides Ann Med Interne 145:581-94
170. 1995 Treatment of resistant Takayasu’s arteritis Clin Rheum Dis 21(1):73-80. Eds: J Cash, R. Wilder
171. 1995 Treatment of corticosteroid-resistant giant cell arteritis Clin Rheum Dis 21(1):59-71. Eds: J. Cash, R. Wilder
172. 1995 Therapy of resistant systemic necrotizing vasculitis: polyarteritis, Churg Strauss, Wegener’s granulomatosis and hypersensitivity vasculitis group disorders Clin Rheum Dis 21(1):41-57. Eds: J. Cash, R. Wilder
173. 1995 Wegener’s granulomatosis: an analysis of 42 patients treated with methotrexate and prednisone Arthritis Rheum 38:608-13
174. 1995 Vasculitic syndromes Curr Opin Rheumatol 7:1-3
175. 1994 Differentiating vasculitides Rheum Dis Clin North Am 20(2):409-42
176. 1994 Emerging concepts in the management of vasculitic diseases Advances Intern Med 39:277-301
177. 1994 Antineutrophil cytoplasmic antibodies (ANCA). Cleve Clin J Med 61:416-27
178. 1994 Treating Wegener’s granulomatosis: how far have we come? Cleve Clin J Med 61:414-5
179. 1994 Wegener’s granulomatosis 1931-1993: changing perceptions of a once fatal disease Cleve Clin J Med 61:412-3
180. 1994 Hypertensive encephalopathy in a young man with undetectable upper extremity blood pressure J Vasc Med Biol 5:69-73
181. 1994 Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selection, intercellular adhesion molecule type I and vascular cell adhesion molecule type I. J Clin Invest 93:17-25
182. 1994 Treatment of glucocorticoid-resistant or relapsing Takayasu's arteritis with methotrexate Arthritis Rheum 37:578-82
183. 1994 Vasculitis Syndromes. Overview Current Opin Rheumatol (Current Science) 6:1-2
184. 1994 Nomenclature of systemic vasculitides: the proposal of an International Consensus Conference Arthritis Rheum 37:187-92
185. 1994 Takayasu’s arteritis Ann Intern Med 120:919-29
186. 1994 Familial vasculitis. a report of 2 families J Rheumatol 21:561-3
187. 1994 Diagnosis of systemic vasculitis in the acutely ill patient Chapter 11. Management of the Critically Ill Patient With Rheumatic or Immunologic Disease, pp. 279-308, 1st Edition. Ed: B.F. Mandell
188. 1993 Limited prognostic value of changes in antineutrophil cytoplasmic antibody titers in patients with Wegener's granulomatosis Advances in Experimental Medicine and Biology. Ed: W. L. Gross
189. 1993 Vasculitis: treatment Primer on the Rheumatic Diseases, 10th Edition, 146-8
190. 1993 Problems in interpretation of head and neck biopsies for the diagnosis of Wegener's granulomatosis Intractable Vasculitis Syndromes. Ed: T. Tanabe, Hakkaido Univ. Press., Sapporo, Japan, pp. 27-52
191. 1993 A longterm prospective study of Wegener's granulomatosis in 23 children and adolescents: clinical presentation and outcome J Pediatr 122:26-31
192. 1993 Wegener's granulomatosis Curr Opin Rheumatol 5:11-17
193. 1993 Arthritis due to deposition of calcium crystals Harrison's Principles of Internal Medicine, 13th Edition. Eds: J.D. Wilson, et al., McGraw Hill
194. 1993 Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis J Clin Invest 91:977-85
195. 1993 Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 36:365-71
196. 1993 Immunosuppressive therapy for autoimmune diseases Ann Allergy 70:1-14
197. 1993 Wegener's granulomatosis Rheumatology, 1st Edition. Eds: J.H. Klippel and P. Dieppe, Mosby, London, June 9, 1998
198. 1993 The vasculitides: classification, diagnosis and pathogenesis. Connective Tissue Diseases: Selected Topics, 1st Edition. Eds: M.A. Khamashta, J. Font and G.R.V. Hughes, Doyma, S.A
199. 1993 Emerging concepts in the management of vasculitic diseases Advances in Internal Medicine. Ed: A.S. Fauci, 39:277-303
200. 1993 Treatment of chronic idiopathic systemic vasculitides Advances in Experimental Medicine and Biology. Ed: W. L. Gross, Plenum Press, 227-34
201. 1993 Mycobacterial and fungal infections Textbook of Rheumatology, 4th Edition. Eds: W.N. Kelly, E.D. Harris Jr., S. Ruddy, C.B. Sledge, W.S. Saunders
202. 1992 The management of subglottic stenosis in Wegener's granulomatosis Laryngoscope. 102:1341-5
203. 1992 Rheumatoid arthritis Current Therapy in Allergy, Immunology, and Rheumatology - 4. Eds: L.M. Lichtenstein and A.S. Fauci, B.C. Decker Inc., pp. 158-63
204. 1992 Dermatomyositis and polymyositis : Current Therapy in Allergy, Immunology, and Rheumatology - 4. Eds: L.M. Lichtenstein and A.S. Fauci, B.C. Decker Inc., pp. 199-201
205. 1992 Wegener's granulomatosis: a prospective analysis of 158 patients Ann Intern Med 116:488-98
206. 1992 SLE and the cardiovascular system: vasculitis Systemic Lupus Erythematosus, 2nd Edition. Ed: R.G. Lahita, Churchill Livingstone Inc., Chapter 31, pp. 719-29
207. 1992 Treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum 35:1322-9
208. 1991 Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients Am J Surg Pathol 15:315-33
209. 1991 Bronchoalveolar lavage analysis in Wegener's granulomatosis: a method to study disease pathogenesis Amer Rev Resp Dis 143:401-7
210. 1991 Intractable vasculitis, resorptive osteolysis, and immunity to type I collagen in Type VIII Ehlers-Danlos syndrome Arthritis Rheum 34:1466-75
211. 1991 Experience with surgical treatment for Takayasu's disease Surgery 109:252-8
212. 1991 Arthritis due to deposition of calcium crystals Harrison's Principles of Internal Medicine, 12th Ed. Eds: J.D. Wilson et al. McGraw-Hill Book Company
213. 1991 Respiratory disease in patients treated with glucocorticosteroids Respiratory Disease in the Immunosuppressed Host, 1st Ed. Eds: J.H. Shelhamer, P.A. Pizzo, J.E. Parrillo and H. Masur
214. 1991 Antineutrophil cytoplasmic antibodies are produced in the respiratory tract of patients with Wegener's granulomatosis Amer Rev Resp Dis 143:275-8
215. 1990 Endothelins, peptides with potent vasoactive, properties, are produced by human macrophages J Exp Med 172:1741-8
216. 1990 Gastrointestinal emergencies. Vasculitis and the gut Current Topics in Gastroenterology and Hepatology. Eds: G.N.J. Tytgat and M. van Blankenstein, Thieme Verlag, p 36-54
217. 1990 Interpretation of head and neck biopsies in Wegener's granulomatosis: a pathologic study of 126 biopsies in 70 patients Am J Surg Path 14:555-64
218. 1990 Treatment of Wegener's granulomatosis with intermittent high dose intravenous cyclophosphamide Amer J Med 89:403-10
219. 1989 Fluoride therapy for otosclerosis Ear Nose Throat J 68:426-9
220. 1989 Pelvic and hip girdle masses as a cause of "hip" pain: the importance of examining the buttock region J Musculoskel Med p 111-22
221. 1989 Granulomatous hepatitis Principles and Practice of Infectious Diseases, 3rd Edition. Eds: G. Mandel, R.G. Douglas, J. Bennett. J. Wiley and Sons, Inc.
222. 1989 Mycobacterial and fungal infections Textbook of Rheumatology, 3rd Ed. Eds: W.N. Kelley, E.D. Harris, S. Ruddy and C.B. Sledge. W.B. Saunders Co
223. 1988 The role of trimethoprim-sulfamethoxazole in the treatment of Wegener's granulomatosis Arthritis Rheum 31:1073-4
224. 1988 Hypoparathyroidism due to progressive systemic sclerosis J Rheumatol 15::711-3
225. 1987 The painful elbow: a guide to differential diagnosis Hospital Med 47-73
226. 1987 Septic bursitis: presentation, treatment and prognosis J Rheumatol 14:1160-3
227. 1987 Gonococcal arthritis Intern Med Specialist 8:177-84
228. 1986 Limitations of the rat remnant kidney model of chronic renal failure: absence of calcium oxalate tissue injury Nephron 4:330-4
229. 1985 Mycobacterial and fungal infections of bones and joints Textbook of Rheumatology, 2nd Ed. Eds: W.N. Kelley, E.D. Harris, S. Ruddy and C.B. Sledge. W.B. Saunders Co
230. 1985 Massive ascites in systemic lupus erythematosus J Rheumatol 12:571-4
231. 1983 Presentation, treatment and prognosis of idiopathic inflammatory muscle disease in a rural hospital Am J Med 75:433-8
232. 1983 Spinal arachnoiditis: what is the clinical spectrum? Part II. Arachnoiditis in dogs: A possible model for human disease Spine 8:541-51
233. 1983 Spinal arachnoiditis: what is the clinical spectrum? Spine 8:538-40
234. 1982 Joint ankylosis in progressive systemic sclerosis Arthritis Rheum 25:1497-1500
235. 1982 Calcium oxalate microcrystalline arthritis in end stage renal disease Ann Intern Med 97:36-42
236. 1981 Intra- and periarticular steroid therapy Amer Fam Phys 23:106-8
237. 1981 Mycobacterial and fungal infections of bones and joints Textbook of Rheumatology, 1st Ed. Eds: W.N. Kelley, E.D. Harris, S. Ruddy and C.B. Sledge. W.B. Saunders Co
238. 1981 Tendinitis and bursitis Amer Fam Phys 23:103-10
239. 1980 Problems associated with the management of pregnancies in patients with systemic lupus erythematosus J Rheumatol 7:37-49
240. 1980 Rheumatoid nodulosis Consultant p. 122
241. 1980 Raynauds disease and phenomenon Amer Fam Phys 21:91-7
242. 1980 Coexistence of systemic lupus erythematosus and myasthenia gravis. Southern Med J 73:244-6
243. 1980 Myoadenylate deaminase deficiency. Muscle biopsy and muscle culture in a patient with gout J Neurolog Sci 47:191
244. 1979 Differential diagnosis of rheumatoid arthritis The Science and Practice of Clinical Medicine. Vol. 4. Rheumatology and Immunology. Eds: A. Grune and Stratton, Inc.
245. 1979 Osteomalacia and weakness complicating jejunoileal bypass. J Rheumatol 5:51-6
246. 1979 Infectious mononucleosis, autoimmunity and vasculitis JAMA 241:2735-6
247. 1978 Thrombophlebitis in systemic lupus erythematosus JAMA 240:1728-30
248. 1978 Septic arthritis associated with Mycobacterium avium: case report and literature review J Rheumatol 5:199-209
249. 1978 Polyarthritis: the differential diagnosis of rheumatoid arthritis Semin Arthritis Rheum 8:115-41
250. 1977 Treatment of Sweet's Syndrome (acute febrile neutrophilic dermatosis) with indomethacin J Rheumatol 4:201-6
251. 1976 Treatment of lupus erythematosus Ann Intern Med 84:337-8
252. 1975 Colchicine: effects upon urinary hydroxyproline excretion in patients with scleroderma. Metabolism. 24:529-35
253. 1969 Sequential chemotherapy with cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in mice with advanced leukemia L1210 Cancer Chemotherapy Rep 53:265-71
254. 1969 Adaptation of a colorimetric determination of 5-(3,3-dimethyl-triazeno)-imidazole-4 carboxamide (NSC-45388) and 5-(3, 3-bis (2-chlorethyl)-1-triazeno) imidazole-4-carboxamide (NSC-82196) to blood Cancer Chemotherapy Rep 53:199-202
255. 1968 Influence of treatment schedules and route of administration on the chemotherapy of murine leukemia L1210 with 5 (or 4)-(3,3-Bis)(2-chloroethyl)-1-triazeno-imidazole-4 (or 5)-carboxamide (NSC-82196) Cancer Chemotherapy Rep 52:715-24


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.